Trevi Therapeutics (TRVI) Property, Plant & Equipment (Net) (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.88% |
| Dec 31, 2025 | -16.43% |
| Sep 30, 2025 | -10.88% |
| Jun 30, 2025 | -13.72% |
| Mar 31, 2025 | 76.43% |
| Dec 31, 2024 | -9.77% |
| Sep 30, 2024 | -12.12% |
| Jun 30, 2024 | -2.94% |
| Mar 31, 2024 | -5.56% |
| Dec 31, 2023 | -9.24% |
| Sep 30, 2023 | 5.78% |
| Jun 30, 2023 | -8.16% |
| Mar 31, 2023 | 44.12% |
| Dec 31, 2022 | 150.00% |
| Sep 30, 2022 | 100.00% |
| Jun 30, 2022 | -19.05% |
| Mar 31, 2022 | -20.75% |
| Dec 31, 2021 | -19.70% |
| Sep 30, 2021 | -15.38% |
| Jun 30, 2021 | -14.29% |
| Mar 31, 2021 | -11.65% |
| Dec 31, 2020 | -6.36% |
| Sep 30, 2020 | 0.92% |
| Jun 30, 2020 | 1.87% |
| Mar 31, 2020 | -9.32% |
| Dec 31, 2019 | -7.81% |
| Sep 30, 2019 | -7.91% |
| Jun 30, 2019 | -6.71% |
| Mar 31, 2019 | 0.00% |